vs

Side-by-side financial comparison of Clearwater Paper Corp (CLW) and Dianthus Therapeutics, Inc. (DNTH). Click either name above to swap in a different company.

Clearwater Paper Corp is the larger business by last-quarter revenue ($360.3K vs $284.0K, roughly 1.3× Dianthus Therapeutics, Inc.). Clearwater Paper Corp runs the higher net margin — -3.6% vs -22687.3%, a 22683.8% gap on every dollar of revenue. On growth, Clearwater Paper Corp posted the faster year-over-year revenue change (-4.7% vs -78.6%). Over the past eight quarters, Dianthus Therapeutics, Inc.'s revenue compounded faster (-44.6% CAGR vs -96.8%).

Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.

Dianthus Therapeutics is a clinical-stage biopharmaceutical firm focused on developing targeted therapies for rare immunological and inflammatory diseases. It advances antibody-based candidates to address unmet needs of severe patients, operating primarily in the U.S. with global development partners.

CLW vs DNTH — Head-to-Head

Bigger by revenue
CLW
CLW
1.3× larger
CLW
$360.3K
$284.0K
DNTH
Growing faster (revenue YoY)
CLW
CLW
+73.8% gap
CLW
-4.7%
-78.6%
DNTH
Higher net margin
CLW
CLW
22683.8% more per $
CLW
-3.6%
-22687.3%
DNTH
Faster 2-yr revenue CAGR
DNTH
DNTH
Annualised
DNTH
-44.6%
-96.8%
CLW

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLW
CLW
DNTH
DNTH
Revenue
$360.3K
$284.0K
Net Profit
$-12.8K
$-64.4M
Gross Margin
-0.2%
Operating Margin
-24486.3%
Net Margin
-3.6%
-22687.3%
Revenue YoY
-4.7%
-78.6%
Net Profit YoY
-103.2%
-126.6%
EPS (diluted)
$-1.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLW
CLW
DNTH
DNTH
Q1 26
$360.3K
Q4 25
$386.4M
$284.0K
Q3 25
$399.0M
$396.0K
Q2 25
$391.8M
Q1 25
$378.2M
$1.2M
Q4 24
$387.1M
$1.3M
Q3 24
$393.3M
$2.2M
Q2 24
$344.4M
$1.9M
Net Profit
CLW
CLW
DNTH
DNTH
Q1 26
$-12.8K
Q4 25
$38.3M
$-64.4M
Q3 25
$-53.3M
$-36.8M
Q2 25
$2.7M
Q1 25
$-6.3M
$-29.5M
Q4 24
$199.1M
$-28.4M
Q3 24
$5.8M
$-25.2M
Q2 24
$-25.8M
$-17.6M
Gross Margin
CLW
CLW
DNTH
DNTH
Q1 26
-0.2%
Q4 25
4.5%
Q3 25
4.7%
Q2 25
11.0%
Q1 25
9.7%
Q4 24
3.8%
Q3 24
7.7%
Q2 24
-0.6%
Operating Margin
CLW
CLW
DNTH
DNTH
Q1 26
Q4 25
1.9%
-24486.3%
Q3 25
-13.9%
-10173.7%
Q2 25
2.5%
Q1 25
-1.1%
-2852.7%
Q4 24
-4.0%
-2406.9%
Q3 24
-0.3%
-1376.6%
Q2 24
-13.6%
-1191.8%
Net Margin
CLW
CLW
DNTH
DNTH
Q1 26
-3.6%
Q4 25
9.9%
-22687.3%
Q3 25
-13.4%
-9284.1%
Q2 25
0.7%
Q1 25
-1.7%
-2537.5%
Q4 24
51.4%
-2144.8%
Q3 24
1.5%
-1159.0%
Q2 24
-7.5%
-945.1%
EPS (diluted)
CLW
CLW
DNTH
DNTH
Q1 26
Q4 25
$2.36
$-1.53
Q3 25
$-3.30
$-0.97
Q2 25
$0.17
Q1 25
$-0.38
$-0.82
Q4 24
$11.87
$-0.76
Q3 24
$0.35
$-0.74
Q2 24
$-1.55
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLW
CLW
DNTH
DNTH
Cash + ST InvestmentsLiquidity on hand
$36.5M
$404.3M
Total DebtLower is stronger
$361.1M
Stockholders' EquityBook value
$813.8M
$493.4M
Total Assets
$1.6B
$530.9M
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLW
CLW
DNTH
DNTH
Q1 26
$36.5M
Q4 25
$30.7M
$404.3M
Q3 25
$34.4M
$402.6M
Q2 25
$46.7M
Q1 25
$44.0M
$263.2M
Q4 24
$79.6M
$275.2M
Q3 24
$35.5M
$281.1M
Q2 24
$39.6M
$360.7M
Total Debt
CLW
CLW
DNTH
DNTH
Q1 26
$361.1M
Q4 25
$346.8M
Q3 25
$337.0M
Q2 25
$330.1M
Q1 25
Q4 24
$283.4M
Q3 24
$1.2B
Q2 24
$1.1B
Stockholders' Equity
CLW
CLW
DNTH
DNTH
Q1 26
$813.8M
Q4 25
$825.3M
$493.4M
Q3 25
$783.0M
$546.5M
Q2 25
$836.8M
Q1 25
$836.6M
$328.6M
Q4 24
$854.6M
$352.5M
Q3 24
$664.6M
$337.9M
Q2 24
$658.6M
$358.2M
Total Assets
CLW
CLW
DNTH
DNTH
Q1 26
$1.6B
Q4 25
$1.6B
$530.9M
Q3 25
$1.6B
$577.4M
Q2 25
$1.6B
Q1 25
$1.6B
$348.6M
Q4 24
$1.7B
$374.0M
Q3 24
$2.5B
$354.2M
Q2 24
$2.5B
$369.0M
Debt / Equity
CLW
CLW
DNTH
DNTH
Q1 26
0.44×
Q4 25
0.42×
Q3 25
0.43×
Q2 25
0.39×
Q1 25
Q4 24
0.33×
Q3 24
1.73×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLW
CLW
DNTH
DNTH
Operating Cash FlowLast quarter
$-47.0M
Free Cash FlowOCF − Capex
$-47.1M
FCF MarginFCF / Revenue
-16591.9%
Capex IntensityCapex / Revenue
48.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-132.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLW
CLW
DNTH
DNTH
Q1 26
Q4 25
$5.0M
$-47.0M
Q3 25
$34.0M
$-30.6M
Q2 25
$-28.2M
Q1 25
$1.5M
$-27.6M
Q4 24
$-35.1M
$-27.4M
Q3 24
$16.2M
$-21.3M
Q2 24
$21.1M
$-14.5M
Free Cash Flow
CLW
CLW
DNTH
DNTH
Q1 26
Q4 25
$-9.9M
$-47.1M
Q3 25
$15.7M
$-30.6M
Q2 25
$-51.1M
Q1 25
$-31.2M
$-27.7M
Q4 24
$-68.1M
$-27.5M
Q3 24
$-30.8M
$-21.3M
Q2 24
$3.0M
$-14.5M
FCF Margin
CLW
CLW
DNTH
DNTH
Q1 26
Q4 25
-2.6%
-16591.9%
Q3 25
3.9%
-7717.2%
Q2 25
-13.0%
Q1 25
-8.2%
-2377.8%
Q4 24
-17.6%
-2072.0%
Q3 24
-7.8%
-980.3%
Q2 24
0.9%
-780.7%
Capex Intensity
CLW
CLW
DNTH
DNTH
Q1 26
Q4 25
3.9%
48.6%
Q3 25
4.6%
1.3%
Q2 25
5.8%
Q1 25
8.6%
2.1%
Q4 24
8.5%
2.3%
Q3 24
12.0%
1.2%
Q2 24
5.3%
0.9%
Cash Conversion
CLW
CLW
DNTH
DNTH
Q1 26
Q4 25
0.13×
Q3 25
Q2 25
-10.44×
Q1 25
Q4 24
-0.18×
Q3 24
2.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons